Tenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFpEF Patients Transcript
· seekingalpha.com
Tenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFpEF Patients August 10, 2026 8:00 AM EDTCompany...
Presentation
Good day, and welcome to the Tenax Therapeutics Phase 3 LEVEL Topline Results Conference Call. [Operator Instructions] Please note this event is b...